Edition:
United States

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

26.00EUR
9 Dec 2016
Change (% chg)

€0.47 (+1.84%)
Prev Close
€25.53
Open
€25.55
Day's High
€26.11
Day's Low
€25.20
Volume
658,472
Avg. Vol
457,857
52-wk High
€29.74
52-wk Low
€19.08

RECI.MI

Chart for RECI.MI

About

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central... (more)

Overall

Beta: 0.53
Market Cap(Mil.): €5,437.25
Shares Outstanding(Mil.): 209.13
Dividend: 0.35
Yield (%): 2.50

Financials

  RECI.MI Industry Sector
P/E (TTM): 23.77 29.73 30.40
EPS (TTM): 1.09 -- --
ROI: 18.23 15.87 15.24
ROE: 24.22 16.99 16.58

UPDATE 1-Recordati names new CEO after death of Giovanni Recordati

MILAN, Aug 16 Italian drugmaker Recordati appointed Andrea Recordati as its new chief executive on Tuesday following the death of his 66-year-old step-brother Giovanni after a long illness.

Aug 16 2016

BRIEF-Richter and Recordati sign license agreement for marketing cariprazine

* Richter has signed exclusive license agreement with Recordati to commercialize cariprazine - statement

Aug 02 2016

BRIEF-Recordati H1 net profit jumps at EUR 122.7 mln

July 28 Recordati Industria Chimica E Farmaceutica SpA :

Jul 28 2016

Earnings vs. Estimates